trial · primary record
CIL001 (Paliroden)
Cochlear Synaptopathy
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 135 |
| Primary completion | 2028-07 |
| Primary endpoint | Frequencies of Treatment-Related Adverse Events with a particular focus on ear and auditory symptomatology |
| Registry ID | NCT07472907 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:56.683Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07472907
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.